Filtros de búsqueda

Lista de obras de

18 F-fluorothymidine uptake in follicular lymphoma and error-prone DNA repair

artículo científico publicado en 2014

2016 ASCO Presidential Address: "Collective Wisdom: The Future of Patient-Centered Care and Research".

artículo científico publicado en 2016

A Phase I/II Multicenter, Open-Label Study of the Oral Histone Deacetylase Inhibitor Abexinostat in Relapsed/Refractory Lymphoma

artículo científico publicado en 2015

A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.

artículo científico publicado en 2009

A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma

artículo científico publicado en 2002

A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.

artículo científico publicado en 2014

A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma

artículo científico publicado en 2012

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

artículo científico publicado en 2009

A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: correlation between clinical responses and AUC pharmacokinetics

artículo científico publicado en 2014

A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma

artículo científico publicado en 2007

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial

artículo científico publicado en 2015

A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma.

artículo científico publicado en 2011

A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma

artículo científico publicado en 2012

A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival

artículo científico publicado en 2002

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

artículo científico publicado en 2008

ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia

artículo científico publicado en 2007

Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP

artículo científico publicado en 2013

Active idiotypic vaccination versus control immunotherapy for follicular lymphoma

artículo científico publicado en 2014

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

artículo científico publicado en 2008

Addressing Administrative and Regulatory Burden in Cancer Clinical Trials: Summary of a Stakeholder Survey and Workshop Hosted by the American Society of Clinical Oncology and the Association of American Cancer Institutes

artículo científico publicado en 2016

Adult Burkitt lymphoma: advances in diagnosis and treatment.

artículo científico publicado en 2008

Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets

artículo científico publicado en 2017

Advances in mobilization for the optimization of autologous stem cell transplantation

artículo científico publicado en 2009

Advances in the treatment of hematologic malignancies. Part 1 of a 3-part series: Aggressive lymphomas

artículo científico publicado en 2006

Aggressive lymphoma: improving treatment outcome with rituximab.

artículo científico publicado en 2002

Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning

artículo científico publicado en 2008

An interview with Julie Vose: where is oncology heading?

artículo científico publicado en 2015

Angioimmunoblastic T-cell lymphoma management

artículo científico publicado en 2013

Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma

artículo científico publicado en 2017

Appropriate Surveillance for Late Complications in Patients in Remission from Hodgkin Lymphoma ⬇️

artículo científico publicado el 1 de septiembre de 2012

Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab.

artículo científico publicado en 2005

Association of number of follow-up providers with outcomes in survivors of hematologic malignancies ⬇️

artículo científico publicado el 1 de octubre de 2010

Atrazine and nitrate in public drinking water supplies and non-hodgkin lymphoma in nebraska, USA

artículo científico publicado en 2013

Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement

artículo científico publicado en 2013

Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease

artículo científico publicado en 2002

Autologous versus Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Chemosensitive Follicular Non-Hodgkin Lymphoma beyond First Complete Response or First Partial Response ⬇️

artículo científico publicado el 10 de noviembre de 2010

Autotransplantation for Mantle Cell Lymphoma ⬇️

artículo científico publicado el 1 de septiembre de 2012

BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma

artículo científico publicado en 2006

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab

artículo científico publicado en 2011

BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma

artículo científico publicado en 2004

Bexxar: novel radioimmunotherapy for the treatment of low-grade and transformed low-grade non-Hodgkin's lymphoma

artículo científico publicado en 2004

Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma ⬇️

artículo científico publicado el 28 de diciembre de 2010

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma

artículo científico publicado en 2018

Building Bridges for Collective Wisdom

artículo científico publicado en 2015

Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion.

artículo científico publicado en 2007

B‐cell lymphoma, unclassifiable, with features intermediate between diffuse large B‐cell lymphoma and burkitt lymphoma: study of 39 cases ⬇️

artículo científico publicado el 18 de abril de 2013

CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma

artículo científico publicado en 2015

CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphoma

artículo científico publicado en 2013

CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience

artículo científico publicado en 2002

Cardiac magnetic resonance imaging for the assessment of the myocardium after doxorubicin-based chemotherapy

artículo científico publicado en 2015

Cell of origin fails to predict survival in patients with diffuse large B‐cell lymphoma treated with autologous hematopoietic stem cell transplantation ⬇️

artículo científico publicado el 18 de octubre de 2011

Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.

artículo científico publicado en 2015

Challenges in Opening and Enrolling Patients in Clinical Trials

artículo científico publicado en 2017

Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015

artículo científico publicado en 2015

Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's disease

scientific article published on 01 December 2003

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

artículo científico publicado en 2008

Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma

artículo científico publicado en 2004

Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease

scientific article published on 20 March 2006

Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project

artículo científico publicado en 2012

Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience.

artículo científico publicado en 2015

Combination therapy for non-Hodgkin's lymphoma: an opportunity for pharmaceutical care in a specialty practice

scientific article published on 01 January 2002

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

artículo científico publicado en 2003

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

artículo científico publicado en 2012

Current status of rituximab maintenance therapy

scientific article published on 01 December 2007

Dendritic cell-based therapy for mantle cell lymphoma.

artículo científico publicado en 2006

Diffuse Large B-Cell Lymphoma Version 1.2016

scientific article published on 01 February 2016

Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring

artículo científico publicado en 2016

Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group

artículo científico publicado en 2004

Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group

scientific article published on 01 November 2003

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome.

artículo científico publicado en 2011

Disparity in survival outcome after hematopoietic stem cell transplantation for hematologic malignancies according to area of primary residence

artículo científico publicado en 2007

Does a diffuse growth pattern predict for survival in patients with low-grade follicular lymphoma?

artículo científico publicado en 2009

Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?

artículo científico publicado en 2013

Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation

artículo científico publicado en 2014

Early-Stage Hodgkin Disease in a 24-Year-Old Woman ⬇️

artículo científico publicado el 1 de diciembre de 2011

Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.

artículo científico publicado en 2006

Effect of linkage of transduction domain sequences to a lymphoma idiotype DNA vaccine on vaccine effectiveness

artículo científico publicado en 2006

Efficacy, safety, pharmacokinetics and pharmacodynamics of SAR245409 (voxtalisib, XL765), an orally administered phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor: a phase 1 expansion cohort in patients with relapsed or refractory ly

artículo científico publicado en 2014

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.

artículo científico publicado en 2011

Establishing an institutional model for the administration of tositumomab and iodine I 131 tositumomab

scientific article published on 01 April 2003

Estimating the State-Level Supply of Cancer Care Providers: Preparing to Meet Workforce Needs in the Wake of Health Care Reform

artículo científico publicado en 2014

Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma

artículo científico publicado en 2005

Follicular large cleaved cell (centrocytic) lymphoma: An unrecognized variant of follicular lymphoma

artículo científico publicado en 2017

Follicular lymphoma in the United States: first report of the national LymphoCare study

scientific article published on 09 February 2009

Follicular lymphoma: expanding therapeutic options.

artículo científico publicado en 2005

Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

artículo científico publicado en 2014

Genetic Cancer Susceptibility Testing: Increased Technology, Increased Complexity

artículo científico publicado en 2015

Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis

artículo científico publicado en 2012

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

artículo científico publicado en 2010

Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?

artículo científico

Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?

artículo científico

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma

artículo científico publicado en 2014

Graft-versus-host disease: how to translate new insights into new therapeutic strategies

artículo científico publicado en 2004

Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.

artículo científico publicado en 2015

Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project

artículo científico publicado en 2006

Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target

artículo científico publicado en 2008

Hematopoietic stem cell transplantation for Hodgkin's disease in a patient with dysfibrinogenemia and thrombosis

scientific article published on 01 April 2007

Hematopoietic stem cell transplantation for non-Hodgkin lymphoma.

artículo científico

High-Dose Therapy/Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Marginal Zone Non-Hodgkin Lymphoma ⬇️

artículo científico publicado el 20 de abril de 2011

Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen

artículo científico publicado en 2002

Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.

artículo científico publicado en 2012

IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma

artículo científico publicado en 2015

Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling

artículo científico publicado en 2015

Imaging in early-stage Hodgkin's lymphoma

scientific article published on 01 March 2010

Immune reconstitution after autologous hematopoietic transplantation with Lin-, CD34+, Thy-1lo selected or intact stem cell products

artículo científico publicado en 2007

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab

artículo científico publicado en 2010

Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for Hodgkin lymphoma

artículo científico publicado en 2013

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.

artículo científico publicado en 2014

Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma

artículo científico publicado en 2009

Improving Outcomes for Patients With Diffuse Large B-Cell Lymphoma ⬇️

artículo científico publicado el 28 de octubre de 2010

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).

artículo científico publicado en 2008

Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomas

artículo científico publicado en 2017

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

artículo científico publicado en 2010

Integrated profiling of diffuse large B-cell lymphoma with 7q gain

artículo científico publicado en 2011

Intensified chemotherapy for diffuse large B-cell lymphomas

artículo científico publicado en 2011

Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma

artículo científico publicado en 2017

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes

artículo científico publicado en 2008

Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome

artículo científico publicado en 2015

Julie M. Vose, MD, President of ASCO--and Editor-in-Chief of ONCOLOGY--Discusses Her New Role and the Importance of Investing Wisely in Cancer Research

artículo científico publicado en 2015

Late relapse in patients with diffuse large B‐cell lymphoma ⬇️

artículo científico publicado el 29 de septiembre de 2010

Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma

artículo científico publicado en 2008

Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma

artículo científico publicado en 2009

Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma

artículo científico publicado en 2009

Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission.

artículo científico publicado en 2014

Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index

artículo científico publicado en 2007

Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation1 ⬇️

artículo científico publicado el 15 de septiembre de 2003

Lymphoma 2006: classification and treatment

artículo científico publicado en 2006

Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care

artículo científico

Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis.

artículo científico publicado en 2013

MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab

artículo científico publicado en 2014

Management of extranodal natural killer/t-cell lymphoma, nasal type.

artículo científico

Management of indolent lymphoma: Where are we now and where are we going ⬇️

artículo científico publicado el 9 de octubre de 2012

Mantle cell lymphoma: 2012 update on diagnosis, risk‐stratification, and clinical management ⬇️

artículo científico publicado el 1 de junio de 2012

Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management

artículo científico

Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management

artículo científico

Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management

artículo científico publicado en 2017

Molecular diagnosis of Burkitt's lymphoma

artículo científico publicado en 2006

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

artículo científico publicado en 2003

Molecular pathogenesis in non-Hodgkin lymphoma: implications for therapy

artículo científico publicado en 2013

Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.

artículo científico publicado en 2013

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

artículo científico publicado en 2009

Mortality patterns among recipients of autologous hematopoietic stem cell transplantation for lymphoma and myeloma in the past three decades.

artículo científico publicado en 2015

Multiple myeloma. Clinical practice guidelines in oncology

scientific article published on 01 February 2007

Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma

artículo científico publicado en 2006

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry

artículo científico publicado en 2004

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

artículo científico publicado en 2002

NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas

artículo científico publicado en 2010

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017.

artículo científico publicado en 2017

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.

artículo científico publicado en 2016

NCCN clinical practice guidelines in oncology: multiple myeloma

artículo científico publicado en 2009

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following All

artículo científico publicado en 2010

NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following all

artículo científico publicado en 2010

Non-Hodgkin lymphoma of the prostate

scientific article published on 02 September 2011

Non-Hodgkin's Lymphomas, version 3.2012

artículo científico publicado en 2012

Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology

artículo científico publicado en 2006

Non-Hodgkin's lymphomas

artículo científico publicado en 2008

Non-Hodgkin's lymphomas

artículo científico publicado en 2011

Non-Hodgkin's lymphomas, version 1.2013.

artículo científico publicado en 2013

Non-Hodgkin's lymphomas, version 4.2014.

artículo científico publicado en 2014

Novel therapy for therapy-resistant mantle cell lymphoma: multipronged approach with targeting of hedgehog signaling.

artículo científico publicado en 2012

Novel treatment for mantle cell lymphoma including therapy-resistant tumor by NF-κB and mTOR dual-targeting approach.

artículo científico publicado en 2013

Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma ⬇️

artículo científico publicado el 15 de abril de 2003

Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma ⬇️

artículo científico publicado el 23 de marzo de 2012

Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.

artículo científico publicado en 2008

Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries

artículo científico publicado en 2003

Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure.

artículo científico publicado en 2011

Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning

artículo científico publicado en 2007

Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.

artículo científico publicado en 2014

Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentr

artículo científico publicado en 2009

Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network

artículo científico publicado en 2018

Peripheral T-cell lymphoma

artículo científico publicado en 2011

Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project

artículo científico publicado en 2011

Peripheral T-cell lymphoma: novel backbone

artículo científico publicado en 2018

Peripheral T-cell non-Hodgkin's lymphoma

artículo científico publicado en 2008

Personalized immunotherapy for the treatment of non-Hodgkin lymphoma: a promising approach

artículo científico publicado en 2005

Personalized immunotherapy for the treatment of non-Hodgkin's lymphoma: a promising approach

artículo científico publicado en 2006

Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma

artículo científico publicado en 2004

Phase 1 trial of bortezomib plus R‐CHOP in previously untreated patients with aggressive non‐Hodgkin lymphoma ⬇️

artículo científico publicado el 27 de julio de 2010

Phase I trial of (90)Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantation

artículo científico publicado en 2007

Phase I trial of iodine-131 tositumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin's lymphoma

artículo científico publicado en 2004

Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma

artículo científico publicado en 2014

Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphoma

artículo científico publicado en 2005

Phase II Trial of 131-Iodine Tositumomab with High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed Diffuse Large B Cell Lymphoma ⬇️

artículo científico publicado el 29 de agosto de 2012

Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma

artículo científico publicado en 2007

Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the

artículo científico publicado el 11 de marzo de 2013

Pitfalls and major issues in the histologic diagnosis of peripheral T-cell lymphomas: results of the central review of 573 cases from the T-Cell Project, an international, cooperative study

artículo científico publicado en 2016

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival

artículo científico publicado en 2007

Polo-Like Kinase 1: A Novel Target for the Treatment of Therapy-Resistant Mantle Cell Lymphoma

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

article

Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective stud

artículo científico publicado en 2014

Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study

artículo científico publicado en 2011

Prognostic factors influencing survival in patients with B-cell small lymphocytic lymphoma

artículo científico publicado en 2004

Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation

scientific article published on 01 April 2005

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

artículo científico publicado en 2009

R-DHAP: a good small step, but not the journey's end.

artículo científico publicado en 2008

Rac1 is a novel therapeutic target in mantle cell lymphoma

artículo científico publicado en 2018

Radioimmunotherapy for stem cell transplantation in non-Hodgkin's lymphoma: in pursuit of a complete response

artículo científico publicado en 2009

Radioimmunotherapy: a novel treatment modality for B-cell non-Hodgkin's lymphoma

artículo científico publicado en 2003

Relapsed diffuse large B-cell lymphoma: clinical utility of cell of origin

artículo científico publicado en 2011

Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography

artículo científico publicado en 2005

Revised response criteria for malignant lymphoma

artículo científico publicado en 2007

Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study

artículo científico publicado en 2017

Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline-Based Therapy

artículo científico

Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation.

artículo científico

Role of radiation therapy in primary mediastinal large B-cell lymphoma in rituximab era: A US population-based analysis.

artículo científico publicado en 2015

Salvage second hematopoietic cell transplantation in myeloma

artículo científico publicado en 2013

Sarcoidosis mimicking recurrent lymphoma ⬇️

artículo científico publicado el 27 de diciembre de 2011

Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.

artículo científico publicado en 2008

Secondary acute myeloid leukemia in survivors of Hodgkin lymphoma

artículo científico publicado en 2016

Senior adult oncology clinical practice guidelines in oncology

artículo científico publicado en 2005

Single-agent lenalidomide is active in patients with relapsed or refractory aggressive non-Hodgkin lymphoma who received prior stem cell transplantation

artículo científico publicado en 2013

Status of ongoing collaborative efforts

artículo científico publicado en 2010

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

artículo científico publicado en 2008

Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study

scientific article published on 14 September 2009

Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database

artículo científico publicado en 2016

Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for

scientific article published on 08 September 2003

Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma

artículo científico publicado en 2008

Ten Years of Progress in the Treatment of Non-Hodgkin’s Lymphoma ⬇️

artículo científico publicado el 1 de enero de 2013

The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study

artículo científico publicado en 2012

The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component

artículo científico publicado en 2008

The Stromal Cell Marker SPARC Predicts for Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab

article

The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell Project

artículo científico

The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma

artículo científico publicado en 2012

The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma

artículo científico publicado en 2011

The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin

artículo científico publicado en 2011

The landscape of new drugs in lymphoma

artículo científico publicado en 2016

The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project.

artículo científico publicado en 2012

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

article

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review

artículo científico publicado en 2010

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin's lymphoma.

artículo científico publicado en 2003

The role of hematopoietic stem cell transplant in follicular lymphoma

scientific article published on 01 March 2010

The role of hematopoietic stem cell transplantation in non-Hodgkin lymphoma.

artículo científico publicado en 2006

Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypes

artículo científico publicado en 2010

To Surveil or Not to Surveil

artículo científico publicado en 2015

Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas

scientific article published on 26 September 2005

Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma

artículo científico publicado en 2009

Understanding evaluation and management of primary cutaneous and systemic ALCL

artículo científico publicado el 1 de junio de 2010

Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes

artículo científico publicado en 2009

Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma

artículo científico publicado en 2009

Update on epidemiology and therapeutics for non-Hodgkin's lymphoma

artículo científico publicado en 2002

Update on lymphoma management: diffuse large B-cell NHL.

artículo científico publicado en 2005

Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma

artículo científico publicado en 2009

Utility of prechemotherapy evaluation of left ventricular function for patients with lymphoma

artículo científico publicado en 2014

Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda